Sorafenib kills liver cancer cells by disrupting SCD1‐mediated synthesis of monounsaturated fatty acids via the ATP‐AMPK‐mTOR‐SREBP1 signaling pathway
Ge Liu, Shan Kuang, Ruobing Cao, Ju Wang, Quancai Peng, Chaomin Sun
The FASEB Journal